Robbie Mcleod PhD

Robbie McLeod (he/him), Ph.D. currently serves as Principal In Vivo Scientist in the Department of Quantitative Biosciences at Merck Research Laboratories (MRL) in Boston.  He has demonstrated 35+ years of success at MRL within the fields of integrative translational pharmacology and physiology contributing to several marketed therapeutics agents. Throughout his career, he has worked across multiple therapy disciplines such as cardiovascular, CNS, allergy, respiratory, immunology, and oncology while providing preclinical pharmacology leadership supporting the development of novel drug entities from target validation, through lead identification and optimization thus enabling phase-1 and proof of concept clinical studies.

Robbie is a classically trained pharmacologist receiving his Ph.D. degree in autonomic pharmacology from the University of Medicine and Dentistry (UMDNJ: 1993) and his MS and BS from SUNY Brockport in 1987 and 1982, respectively. Dr. McLeod holds several patents, is the author of numerous scientific publications, and book chapters, and has been an invited lecturer at national and international meetings.  In 2011 he was awarded a Distinguished Alumni award and citation by UMDNJ for his commitment to his science endeavors and his community outreach activities.